STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] COMPUGEN LTD Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Compugen Ltd. (CGEN) filed a Form 6-K

The report was signed by Eran Ben Dor, General Counsel, on November 10, 2025. Investors seeking financial details should refer to Exhibit 99.1, which contains the full Q3 2025 results.

Positive
  • None.
Negative
  • None.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025
Commission File Number 000-30902

COMPUGEN LTD.
(Translation of registrant’s name into English)

26 Harokmim Street
Holon 5885849, Israel
(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒  Form 40-F ☐



Compugen Ltd.

On November 10, 2025, Compugen Ltd. (the “Company”) issued a press release reporting the Company’s third quarter 2025 results (the “Press Release”), a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K.

With the exception of the quotes attributable to Eran Ophir, Ph.D., information contained in the Press Release is hereby incorporated by reference into the Company’s Registration Statement on Form F-3, File No. 333-270985.

Exhibit
Number
Description of Exhibit

99.1
Press Release dated November 10, 2025 – “Compugen Reports Third Quarter 2025 Results”



Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
COMPUGEN LTD.
 
Date: November 10, 2025
By: 
/s/ Eran Ben Dor
 
 
 
Eran Ben Dor
General Counsel
 


FAQ

What did Compugen (CGEN) file?

A Form 6-K furnishing a press release containing the company’s Q3 2025 results as Exhibit 99.1.

Is the press release part of Compugen’s shelf registration?

Yes. Except for quotes by Eran Ophir, Ph.D., it is incorporated by reference into Form F-3 File No. 333-270985.

Where can I find the Q3 2025 financial details for CGEN?

In Exhibit 99.1 to the Form 6-K, which contains the full Q3 2025 results press release.

Who signed the Form 6-K for Compugen?

Eran Ben Dor, General Counsel.

When was the Form 6-K dated?

November 10, 2025.

What content is excluded from incorporation by reference?

Quotes attributed to Eran Ophir, Ph.D., are excluded from incorporation into the Form F-3.
Compugen

NASDAQ:CGEN

CGEN Rankings

CGEN Latest News

CGEN Latest SEC Filings

CGEN Stock Data

156.20M
91.64M
2.03%
16.56%
1.01%
Biotechnology
Healthcare
Link
Israel
Holon